COVID-19 and Kawasaki Disease: Novel Virus and Novel Case
Palo Alto Institute · Stanford Medicine · +1 more institution
Abstract
In the midst of the coronavirus disease 2019 (COVID-19) pandemic, we are seeing widespread disease burden affecting patients of all ages across the globe. However, much remains to be understood as clinicians, epidemiologists, and researchers alike are working to describe and characterize the disease process while caring for patients at the frontlines. We describe the case of a 6-month-old infant admitted and diagnosed with classic Kawasaki disease, who also screened positive for COVID-19 in the setting of fever and minimal respiratory symptoms. The patient was treated per treatment guidelines, with intravenous immunoglobulin and high-dose aspirin, and subsequently defervesced with resolution of her clinical…
Citation impact
- FWCI
- 154.45
- Percentile
- 100%
- References
- 14
Authors
10Topics & keywords
- Medicine
- Kawasaki disease
- Coronavirus disease 2019 (COVID-19)
- Pandemic
- Aspirin
- Disease
- Pediatrics
- Pneumonia
- Good health and well-being